Koers Stereotaxis Inc OTC Bulletin Board
Aandelen
Geavanceerde medische apparatuur & technologie
slotkoers
Andere beurzen
|
||
- USD | - |
24/05 | Stereotaxis ontvangt hercertificering CE-markering in EU | MT |
13/05 | Transcript : Stereotaxis, Inc., Q1 2024 Earnings Call, May 13, 2024 |
Omzet 2024 * | 29,5 mln. 27,2 mln. | Omzet 2025 * | 44,25 mln. 40,8 mln. | Marktkapitalisatie | 163 mln. 150 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -19 mln. -17,52 mln. | Nettowinst (verlies) 2025 * | -16 mln. -14,75 mln. | EV/omzet 2024 * | 5,51 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 3,67 x |
K/w-verhouding 2024 * |
-8,43
x | K/w-verhouding 2025 * |
-10,6
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 84,22% |
Recentste transcriptie over Stereotaxis Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Fischel
CEO | Chief Executive Officer | 57 | 29-09-16 |
Kimberly Peery
DFI | Director of Finance/CFO | 55 | 01-01-03 |
Laura Garth
LAW | General Counsel | - | 01-01-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Messey
BRD | Director/Board Member | 78 | 01-05-05 |
David Fischel
CEO | Chief Executive Officer | 57 | 29-09-16 |
Nathan Fischel
BRD | Director/Board Member | 68 | 03-02-17 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+10,03% | 223 mld. | |
+13,59% | 195 mld. | |
+20,01% | 144 mld. | |
+30,83% | 111 mld. | |
+2,05% | 65,01 mld. | |
+15,38% | 53,02 mld. | |
+3,96% | 50,45 mld. | |
+8,37% | 44,15 mld. | |
+3,27% | 36,45 mld. |
- Beurs
- Aandelen
- Koers STXS
- Koers